RNA Atrium Therapeutics insider & Congress trades
Atrium Therapeutics, Inc.
InsidersPoliticiansBig moneyPunditsShort interestDividendEarnings
🔒 Unlock everything on RNA
Subscribers see every insider trade, the dividend safety rating, pundit hit rates and watchlist alerts.
Subscribe$9.99/month, renews automatically each month until you cancel. Cancel anytime from your account page.Insider trades
0 insider trades in the last 90 days.
No SEC Form 4 insider trades on file for RNA yet. We check EDGAR hourly.
Politician trades
No member of Congress has disclosed a RNA trade in our data yet.
Big money
4 13D/13G big-stake filings (5%+ owners) on file.
Who called RNA?
None of the pundits we track has made a call on RNA yet.
Short interest
Open short positions in RNA as of the Oct 30, 2026 settlement.
Recent settlements
Shares short at each FINRA settlement date (newest on the right).
Data: FINRA, as of Oct 30, 2026. Shares outstanding from SEC XBRL as of Aug 3, 2026. Short interest is a twice-monthly snapshot of open short positions reported by broker-dealers under FINRA Rule 4560. It is not a live figure. FINRA Equity Short Interest ↗
Is the dividend safe?
RNA isn't in our dividend safety list (it may not pay a regular dividend).
Earnings releases
1 earnings release on file. Reported results only.
-
1
Q3 2026filed Nov 12, 2026🔒 Headline figures and summary for subscribers.
Sources: SEC EDGAR (Form 4, 8-K, Schedule 13D/13G, 13F), FINRA consolidated equity short interest, House periodic transaction reports, public posts on X, and our price data for returns. We never show share prices. Not investment advice.
Watchlists are for subscribers. Get alerts from your watchlist.
Sign up